MLKL and anemia: Consistent with the decreased intestinal polyps in the anti-IL-6R-treated Apcmin/+Mlkl-/- mice, the anemia and thymus atrophy in the Apcmin/+Mlkl-/- mice were considerably alleviated after anti-IL-6R treatment (Figure S5B, S5C).